Tuberculosis PK 2017

10th International Workshop on Pharmacology of Tuberculosis Drugs

We are pleased to announce the 10th edition of the International Workshop on Pharmacology of Tuberculosis Drugs which is scheduled for 15 October 2017 in Atlanta, USA.

The treatment of Tuberculosis is increasingly becoming a challenge worldwide. All around the world experts in the field are involved in intensive research to be able to cope with the various concerns with regard to treatment.

The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field. Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed.

The format of the meeting will be a one-day workshop consisting of invited lectures, abstract presentations and roundtable discussions. Much time will be allocated to questions, answers and discussion in order to set up an intimate interactive workshop.

Topics that will be addressed include pharmacokinetics and pharmacodynamics of new TB drugs, Pharmacokinetics and pharmacodynamics of approved TB drugs, Pharmacokinetic – pharmacodynamic modeling, Drug-drug and drug-disease internactions, New TB drug development tools, new developments in pediatric TB, interactions between TB and HIV drugs, and treatment of MDR- and XDR-TB.

The target audience of this meeting consists of clinical pharmacologists, pharmacists, industry researchers, ID doctors, pediatricians, microbiologists, government representatives and other experts with an interest in clinical pharmacology.

We invite you to attend the 10th International Workshop on Clinical Pharmacology of Tuberculosis Drugs and encourage you to submit abstracts on your research in this field.

Kind regards,

Rob Aarnoutse PharmD, PhD (Chair 2017) – Radboud University Nijmegen Medical Centre, the Netherlands
Geraint Davies MD – University of Liverpool, United Kingdom
Helen McIlleron MBChB, PhD – University of Cape Town, South Africa
Khisi Mdluli PhD – TB Alliance, USA
Eric Nuermberger MD – Johns Hopkins University, USA
Charles Peloquin PharmD – University of Florida, USA

The Organizing Committee